0001493152-24-018484.txt : 20240509 0001493152-24-018484.hdr.sgml : 20240509 20240509164310 ACCESSION NUMBER: 0001493152-24-018484 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240507 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOXYTRAN, INC CENTRAL INDEX KEY: 0001445815 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 262797630 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35027 FILM NUMBER: 24931478 BUSINESS ADDRESS: STREET 1: C/O BIOXYTRAN, INC. STREET 2: 75 2ND AVE, SUITE 605 STE 605 CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 617-494-1199 MAIL ADDRESS: STREET 1: C/O BIOXYTRAN, INC. STREET 2: 75 2ND AVE, SUITE 605 STE 605 CITY: NEEDHAM STATE: MA ZIP: 02494 FORMER COMPANY: FORMER CONFORMED NAME: U.S. RARE EARTH MINERALS, INC. DATE OF NAME CHANGE: 20181005 FORMER COMPANY: FORMER CONFORMED NAME: U.S. RARE EARTH MINERALS, INC DATE OF NAME CHANGE: 20110512 FORMER COMPANY: FORMER CONFORMED NAME: U.S. Natural Nutrients & Minerals, Inc. DATE OF NAME CHANGE: 20091029 8-K 1 form8-k.htm
false 0001445815 0001445815 2024-05-07 2024-05-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 7, 2024

 

BIOXYTRAN, INC.

(Exact Name if Business Issuer as specified in its Charter)

 

Nevada   001-35027   26-2797630
(State or other Jurisdiction
of Incorporation)		  

(Commission

File Number)

   (IRS Employer
Identification Number)

 

75 2nd Avenue,
Suite 605

Needham MA, 02494

(Address of principal executive offices, including zip code)

 

(617) 494-1199

(Registrant’s telephone number including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 1 4a- 12 under the Exchange Act (17 CFR 240.1 4a- 12)

 

☐ Pre-commencement communications pursuant to Rule 1 4d-2(b) under the Exchange Act (17 CFR 240.1 4d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 1 3e-4(c) under the Exchange Act (17 CFR 240.1 3e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001   BIXT   OTCQB

 

 

 

 

 

 

Item 4.01. Change in Registrant’s Certifying Accountant.

 

On May 7, 2024, Bioxytran, Inc. (the “Company”) dismissed BF Borgers CPA PC (“BF Borgers”) as its independent public accountants and appointed Fruci & Associates II, PLLC (PCAOB #5525) (“Fruci”) as its new independent accountants. The decision to dismiss BF Borgers and to retain Fruci was recommended by the Company’s Audit Committee and approved by its Board of Directors.

 

BF Borgers’s reports on the Company’s consolidated financial statements for each of the years ended December 31, 2023 and 2022 did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles.

 

During the years ended December 31, 2023 and 2022, and the subsequent interim period through March 31, 2024, there were no disagreements between the Company and BF Borgers on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to BF Borgers’s satisfaction, would have caused them to make reference to the subject matter of the disagreement in connection with their report.

 

None of the reportable events described in Item 304(a)(1)(v) of Regulation S-K occurred during the years ended December 31, 2023 and 2022 or during the subsequent interim period through April 19, 2024, date of submission of the 10-Q for the three months ended March 31, 2024 and 2023.

 

Bioxytran has requested that BF Borgers furnish it with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the above statements. The letter, dated May 8, 2024, is attached as an exhibit to this Form 8-K.

 

During the years ended December 31, 2023 and 2022, and the subsequent interim period through May 8, 2024, the Company did not consult with Fruci regarding any of the matters or events set forth in Item 304(a)(2)(i) and (ii) of Regulation S-K.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit    
Number   Description
16.2   Dismissal Consent from BF Borgers CPA PC, dated May 8, 2024
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  By: /s/ David Platt
  Name: Dr. David Platt
  Title: President and Chief Executive Officer
   
  Dated: May 9, 2024

 

 

 

 EX-16.2 2 ex16-2.htm

 

Exhibit 16.2

 

 

5400 W Cedar Ave

Lakewood, CO 80226

Telephone: 303.953.1454

Fax: 303.945.7991

 

May 8, 2024

 

United States Securities and Exchange Commission

Office of the Chief Accountant

100 F Street, N.E.

Washington, D.C. 20549

 

Re: BioXyTran, Inc.

 

Ladies and Gentleman:

 

We have read the statements under item 4.01 in the Form 8-K dated May 8, 2024, of BioXyTran, Inc. (the “Company”) to be filed with the Securities and Exchange Commission and we agree with such statements therein as related to our firm. We have no basis to, and therefore, do not agree or disagree with the other statements made by the Company in the Form 8-K.

 

Sincerely,

 

 

BF Borgers CPA PC

Certified Public Accountants

Lakewood, CO

 

 

 GRAPHIC 3 ex16-2_001.jpg begin 644 ex16-2_001.jpg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ex16-2_002.jpg begin 644 ex16-2_002.jpg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end EX-101.SCH 5 bixt-20240507.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 6 bixt-20240507_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 7 bixt-20240507_pre.xml XBRL PRESENTATION FILE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
May 07, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date May 07, 2024
Entity File Number 001-35027
Entity Registrant Name BIOXYTRAN, INC
Entity Central Index Key 0001445815
Entity Tax Identification Number 26-2797630
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 75 2nd Avenue
Entity Address, Address Line Two Suite 605
Entity Address, City or Town Needham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02494
City Area Code (617)
Local Phone Number 494-1199
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001
Trading Symbol BIXT
Entity Emerging Growth Company false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://bioxytraninc.com/role/Cover Cover Cover 1 false false All Reports Book All Reports bixt-20240507.xsd bixt-20240507_lab.xml bixt-20240507_pre.xml form8-k.htm http://xbrl.sec.gov/dei/2024 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "BIXT", "nsuri": "http://bioxytraninc.com/20240507", "dts": { "schema": { "local": [ "bixt-20240507.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "labelLink": { "local": [ "bixt-20240507_lab.xml" ] }, "presentationLink": { "local": [ "bixt-20240507_pre.xml" ] }, "inline": { "local": [ "form8-k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://bioxytraninc.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-07", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://bioxytraninc.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 17 0001493152-24-018484-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-018484-xbrl.zip M4$L#!!0 ( &2%J5C+,1_J+@, .\+ 1 8FEX="TR,#(T,#4P-RYX M],_T'E'?"EN=BQDVF22<83I\G8N;AYZ0@0MB9"HI+P)5]? M"1"^8+NVV_(D5N>(",]JVJD[% HCZ+,!TV+:>^_:W_E6G M8X&+\\^?@'I:7VP;W&!$@B:X9K[=H2$[ ]]AA)K@%E'$H63\#+Q DF@+N\$$ M<7#%HI@@B=1&YJD)CIQ:S0.VO8/N"Z(!X\^]3J$[DC(63=>=3"8.96,X8?Q= M.#Z+=A/L2R@34:A5II7\V8U^CX5?D!O'][$XF?;P8(CH:7(-Z42\PMN[6^^Q M\7'T=IJ@]]'X]?+#>XZ.^>PK#\E;XV[6._WQ,HK\ 7O(7+:$/T(1!*H85+0M MG5^>WJ3N,#YT:Y5*U1W<=_LISLJ S2G!]'T=O-IH--QTUT!+R*G'B9&NNWK; M@P(5RFH7;\%C*B2D_A(^D 5A$7SD9IM+4+P6>IQ!L8$&: 4GD.\,V=A5&PI? M^VJ B;"'$,8%.(3"2T7SC26PX+(,5,95D"UG,1)KH=G6$N&R,W@JL!YFTYGD MD&+JZ[Y,D96CRHF:+H(B1.4-X]$U"F%"5#"_$DAPB%%@ 0GY$$G=:"*&/MI! MT70LI)2IQE;3E5NT+8ZQZMS"H$RZTDW."'I2*0"]4).UV8T&N%=,W1 6P$'; MRI8+@D8R0"&F.'6?3U,5V'IV$IVN6J;,EKL*+BLE @4/]#Q=QQP)14_3ZBI# MSL\AV[D^)'Y"#J+.X]O&S.WF,$NG;(:JAT*0#F-3MTW;$EA?AU9N&W$4MBT/ M3Z5M:OI3I>VHMC(0[6'+,*8U6CVIW+&1@-POJ90N"R7"8L0E5KV]<"-DH6.I MZ8\+;H#V(RS@_L/,"?3VS5Q1$/F/*7>U?CG7EKL\7>I]=0);*EW&):"E<=YV MHV;?@B[S4ZDM%/UF&YZM37:U9M>KSE0$\TCW"6)^ OL%87@'!+'A7E_G7VR" MZT7:0KLZW?!]V.IT+<=%1 IC.3B$Q:_)7\20RNP5Q%(Y \E=+:%%:[:J8[VZ M.9P_,=-W<5 3^"RADL_V:81%BGDYK!KS_X#="F'P61'TK\&A;@_H@K+S=2W0 M41%FB>"0E14G.Q8Q'? _U4GQ,4E_'GW[<;2AZ M(2)-.#L?'1]]'"'"(AXG;'T^^KH87RQF\_D(I1EF,::(I M/8KX9EB%BPQGV[2J[>/N8_FG"/]$$_9TIOY:X90@>;Q8>K9+D_.1VF^YV]>3 M(R[6D^G'C\>3?_YRO8@>R0:/$Z:.6T1&.DK58HL[/CT]G>2E6MI2[E:"ZGV< M3+2=JF99FG3H:T[2Y"S-[5WS"&=YM_?N!H$*];^QEHW5IO'Q='QR?+1+XY$^ M^/D1%)R2>_* \F:>9?MGB5*:*!)&Y;9'01[L9J@0$Q4_862-,Q*K'9VJ'1W_ M7>WHS^7F:[PB=(244O(!MNNT45<9-'%M]HZ(A,>7['VNS6A/]N5W1V3_0P/J M\E:Y/_%=M:V_.;#:S^N5&V\ MEI\:%LDNDQ,8B;5)547'")SO(9\8RKJKVGG4J)>JT9R+=MO5S)C7F9+H:,U? M)C%)9-W3[]2'L?J0-UO^Y_<9ERN!BU6:"1QENJ:\&>I=+2A4J&65(2-ORY&/^0:])M6_>?3Y%"+@XZ62Z#MAK!L*6NTM*!9 M[*J;;:9T+]?+@NADBR&SC[4$*8WC#KZ0.X[5SJ\H7EOL&^6NNMAJ2_=QHS"( M3K8Y,GNYTB E\M7-7T@:B>19+>>[VM&0.>]TB\E6W]M=#?Z=M0$ JN5]&E@*S-%$#6"\D;:GSTPW ;.O4P] %Q0E@#CXEJ?1^25D\ M$DK5_0#,^@<4F]@U+;!ADY>V,BAB0'L@,WD$*D/"P>;R1:W.Y3)I8&-K>I_P MM&QW\5.)@T7(=#B0HCP,J3A/)-5N0_0PU%*ZI@>P:G)CR((BQNX-9*60HUSO M'Y)+%@]"I-+Y <2P:<>C% 4(1]-9'QI2[1.,JR2-,"V\7,EM:4?S+%K7@(!V M34A:PJ! @=R!L!0!FID\Q"LP_R)8#,.EIO0#2\NJ'95*%B HIK<^3)3>"R2S MK1 -U_", TN=W93M,5O=GP5T08#28ZYUU[:0-T#Q- -=LBS)]NIYNIOM9D6$ MI7%MB2LV('.:";,\"!8 4R8#A0PI'2J$7GI>WR5@F7J($6R.*7-+@-UDDX*F M)B 2K,8 &@[:_)E2+T3,Y,@D,)VSF.Q^)GNP72V=6R8 FTTH#%% 5-B= 5B4 M8I2KD91[ >-.)!LL]HLDZIDJVD*W:$!&FVR8JH#@ *P!=)1JM)C/?,XD2[R; MQQ+4Y"$IG@?OH034NX6EQW:3&4 <$#K=#@&"9!!J1OD$:H,"0BP(3X!S!JA'XIG4A!7[_'D%2!5@Q?B+N)8 M'JBT_.08;+]5ZY:N#KM-IBS"@$B"W0'\E,H/^@-2,>B6A0+-] U-G?J' M9CH4FFG0T$S? \WRE0<"S6M#Q85H-8S*L0G)OG"ZE;<"?Z2L A>,D-R+\ MIJW4&-KPT+$;[..G6A#K.*]C3;$H[_V2:)F?4:9ITC[$%)KP(&D:ZQU<"K5/ M).YXFF'Z[^2Y\T3<+O:"A]6P%9*&,CQ4;/;Z@"EBD SR<6)=XJIN:%A?)3/* MW;T";+%U> 6X5A@$!#9'[5> BZLGANY#.4Z3U?C M58:)U#Y\U\JRFG6HBUP5!]*[IIC5-ZW+'O?FK2#*YYQG?;+:LO,MC>VX0 MT+GJY4Z;NL>MHB!ZO\N924*I14VQ8RP6G"91DB5L_8L\^10)MK7*)G(%!&Q0 MT]!6!($":,ODX"!$6ND8@CM!%(1$=D3^$J!*+"1N'QZLLWV7V!44_88U'+ R M"$AZ[9FPR(!Q5(M 10C*8_QB,T_3+1%O@L<2X@DAT#P 4DL?(DZ0R5ZHBD"? M;"U(M)7SX_YXNEHF&;6=7+8ESN8DP%PU(QGE0; !F#)9R,L0?T#'T[^L_HIT ME./NO^%+@57RV,5^L^(4R#YE5;F"H,.BYL B"0(%V)=)PPU'I1056A_9J1IF M+N>1< ZQ$7 >N@B8.UM$:!W6Z0( MD>/2[8HF:PPD)^Q4NX:BP[+)AT4:%"JP/W#,J$+0(<9U1LL\Q9E*SR\V^?ZO MY =+*P&=LYR673:KI)8V41",=#EKI;4LDL[5Q$BI77.QC9.,Q(69JX1A%B68 M5ND1;5?$^T.2 MOG&Z91D6^;ODPC8R 3JWY VF\08HH!(L3L#"*G$J%#[>4&[R!Y1+;**WQT" M&PC)';^NW6G:>&O;J@V(F4Z#T#O<94L9(V9RJ;7F'4^)&RKWB6-: M%MNY8RI)0'C8?'5DD!%(:[VPL-A@2C]OTX21%)Z(#)5;%JP6FRPT) &Q8/,% ML)!+D=9Z8>%R0\1:3F\_"?Z:/9;Y6<&V 6JW;'1:;C)BE0;$2I<_@!D=@HH8 MG5+7#SR[0T+Q(LLBW%*+U#$VH%F#F98N)& @5CSY#H/ M1"K29S:C>G)[>(G7$#E>&5L,&@OCFB((1D!;T+*X_EL!?G+G;59-36K2-"@T(,[>XA<@\% %JM7QH39C^;R8IQX:5]G<>/2T>,3R M -YNLU3-H-(8?!6\,\CQ[84!#3!N,G1$!(3> )O0#8<\$N6A'U 1C&K1GL[/ MTD,60!)_WM^3!R+4>P=+LLL^RQT]=9QA#(AU??8VN#GFR5QO8! 0OM4M=*J7 MHGH%:*6>$2NK0+^I2E!>B^WWR^N;KN4GN5EODG^M<$KDEO\"4$L#!!0 ( M &2%J5CWB0@R6P< -U7 5 8FEX="TR,#(T,#4P-U]P&ULS9S? M4]LX$,??;^;^!U_N.82$]GI0N ZDI),I!8[0]NY>.HJM)!ID*2/))/GO3[+C M-#\L>7GQP@,$9R7M][.R[+4DGW]8ICQZIDHS*2Y:W:/C5D1%+!,FIA>MKZ/V MY:@_'+8B;8A(")>"7K2$;'WXZ]=?(OMS_EN['0T8YI]](WPS!V1 \:IBOHRG7-JJ/VB:/@L>GO4ZXVC=AM0[SNS3F>Q6!P)^4P64CWIHUBFL I'AIA,;VH[7AZO?XKBYYR)IS/W M:TPTC2POH<^6FEVT7+OK9A6R['B91LGG=*=3H)*=*3JY:(W9TM@6>F^.WQZ_<_7_OF-D5G/;.35S?:L5=7;:GBNJ MJ3"YW!M[8*<(71K;I6A25N3:?XEWAAE78-UINE';]; LM>W9CX7EVIG2'2[C M'0^XBX3_3=N N51Q)E5!E69=U$17OA.NP@ZXM.G.B M;$7M>,;X)M(3)5,?G34)Z7%T&Y1MHAF:E[;]Q/DPX&1:C7//!,BSBP&T4@T6 MT8]4QXK-'9<:L#N60+X]5+X5VAK&7)X[#W3*G+_.%7?9I>Y@>%SP% &"/\$< M*8)JD2)P*41&^ .=2U4#?M<2R/L-)N\J;4B8_\Z(,E3Q%83T@3$0]EM,V!Z% M2+P?[1V:9HX/!/BA-9#X'Z@W'AZ-2,A',\JY2^6( /7R*GL@]G>8V/TZ7P'X MZV=W?;>7%CC[K2) _'^^%OP':I$B<$\5DXF]I"L ^P-C(/533.H>A:B\KT4" MI;TQ!><_^+#WY"&A'C =$UYX-+#'=!AWA3D4.4K.62L3%?N_E"@P]"UC*'*4 M-+1&8L/ ^YE2.\X$1Q6_-10Y2@):)[)AYM?",+-RS_YOLW3\\\'I+NM#*RAC ME*33)PJ%;?FD01@WI1'BNV\)98R2:X;$H7#N6SV*\*%(Z/(S785 'YA"2:/D MF$%Y**CO%4N)6HU87#]H'-I"8:-DEF&!*+0?R7*86%5LPHI)P7KHWB)0]BAI M)4@N2@B&(I9J+K<>%_=E9L_'55\FP2&]IB T'"CYY@NDHP3E,DDL+KW^<\,$ M[89"46D.GB/""T! YBO!WGL9]AX<.TH>6BOSE6 _>1GV$SAVE%RT5B8F]K[] M>*<>Y<(S ^TUAB)'R45K)&("SZ\T=^I>R6=6K(VJHWY0 HH>,44-BT7M\,5% M'M+;2TLH;\1TM5H<)N=[J0WA_[%YW9UDM3V4.6+B&A+:] /&(N[NH85O*=&> M"90O2JY:*:=II"["BA)_]]VU@ )%24"KQ#3,\T:ZN8^9%,'GL8=64*XHF:1/ M5-,#KUM,K+VG_M;7X!5L*,/JOHR&,7Y7S%@/^C)-,[%^1N.9%?.80O&BI']! M>0VC'DG.8F:8F'ZQ=XB*$5[-N=N?KN-QN W4W MF?A&WI ]E#A*KE$:9 RLH:Y24SR>J8;:W\E$1MV=OM$K'DONWAU0:0@FC)'@!:0U#WO&C&N^> M"10L2F97*0=I3+A>QC,BIM2_>J':$@H8)=,+B4,;>Z>@L7?ZPK$7)>/SB4)B M6ZP-MV?4W9BS*?'O) L6 .^SP20>D-KT_KU\RX_;S:W2W(^!_5"-W6,*!8ZS M13(DKVG46<(,30J7!DP0$=N4:K.OS9.=UY>"!@!G#R50-,KC_>^4\\]"+L2( M$BT%38I;_= 3?F\1:!00YQ!KY**$X)ODF:6D\H6@RG,.>$RAR!'G#CWR<-9> M%HN:-]>>XK4=(>*^$E#PB).(8;%(Z],,=3ZS9_J1&++V,,3?5P+*'W%",2P6 M;?V\ZML+SU2&Y\SW#*&T$9?"5DI#@3Q*">=7F6:"ZN#8LF<(A8RXYK52&@KD MZY2JJ1W4/BFY,+/UWLX0;$\!*'3$E:U!J3CPES_WD1?[WX+D*ZS!;R= Q.X5 MB?7:C3AV"RF**[E(B/)0#]E#N:-NK/0+;9C\G9E1M7W_E#LSM'E;:-%#?2EH M%%#25:AHG&OKUD[^X*5UQP[*&S$QK1*&LV>= UXT]X-Y36WSC?KEWL=HC_P-02P,$% @ M9(6I6$AR?^ ;! 5A4 H !E>#$V+3(N:'1MY5AM;]I($/X>*?]A#NFB M5L+&$,@%<"+QFJ(CB15\U^NGTV*O\;:VEZZ7$.[7=];&.8>DXLV5[E0^ +9G MGYEY=F:\,^8'^W9\?7IB?AAT^O@+ZF/:(WL\N#8KZ2\^K:P?F]W[_B>8V)_& M@ZN2QR/9@JHQEV"SD,9P1Y?PP$,2E=,;99A0P;P2+L2E5K8N)&+&HA88I6NS M>WT63>-YVZQT49_U/O9\OU1Z;]L#_\(Q62.23(7)-\_I:O*K), MN[\__MK&>A---(?W=W8>0O-(R()5:QM((ANS?VBJ$Y%&MS

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end XML 19 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001445815 2024-05-07 2024-05-07 iso4217:USD shares iso4217:USD shares false 0001445815 8-K 2024-05-07 BIOXYTRAN, INC NV 001-35027 26-2797630 75 2nd Avenue Suite 605 Needham MA 02494 (617) 494-1199 false false false false false Common Stock, par value $0.001 BIXT